{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-026871","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2022-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.998423+00:00","generated_at":"2026-06-23T07:13:15.126154+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Propanc Biopharma issues $71,500 convertible note to GS Capital","bullets":["Principal $71,500 with $4,000 OID; net proceeds $67,500 for general working capital.","Note bears 8% interest; convertible at $0.002/share (fixed) or $0.0009 if stock below $0.0014 for 5 days.","Maturity March 21, 2023; prepayment premiums of 110%-130% depending on timing.","Default conversion price at 65% of lowest trading price over 10 days; default interest 24% per annum.","GS Capital paid $2,500 legal fees; conversion limited to 4.99% beneficial ownership."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-026871","json":"https://secwatch.observer/filing/0001493152-22-026871.json","markdown":"https://secwatch.observer/filing/0001493152-22-026871.md","text":"https://secwatch.observer/filing/0001493152-22-026871.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315222026871/0001493152-22-026871-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315222026871/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T07:13:15.126154+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}